12
Views
8
CrossRef citations to date
0
Altmetric
Experimental Surgery

Oral Fluvastatin Reduces the Severity of Peritoneal Adhesions in Rats

, , , , &
Pages 66-70 | Published online: 11 Mar 2016

References

  • Menzies D., Ellis H. Intestinal obstruction from adhesions: how big is the problem ? Ann R Coll Surg Engl, 1990, 72: 60–63.
  • Menzies D., Parker M., Hoare R., Knight A. Small bowel obstruction due to postoperative adhesions: Treatment patterns and associated costs in 110 hospital admissions. Ann R Coll Surg Engl, 2001, 83: 40–46.
  • Jeekel H. Cost implications of adhesions as highlighted in a European study. Eur J Surg Suppl, 1997, 579: 43–45.
  • Ellis H., Moran B. J., Thompson J. N., Parker M. C., Wilson M. S., Menzies D., McGuire A., Lower A. M., Hawthorn R. J., O’Brien F., Buchan S., Crowe A. M. Adhesion-related hospital re-admissions after abdominal and pelvic surgery: A retrospective cohort study. Lancet, 1999, 353: 1456–1457.
  • Ray N. F., Denton W. G., Thamer M., Henderson S. C. ., Perry S. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg, 1998, 186: 1–9.
  • Van der Wal J. B., Jeekel J. The use of statins in postoperative adhesion prevention. Ann Surg, 2007, 245 (2): 176–184.
  • Liakakos T., Thomakos N., Fine P. M., Dervenis C., Young R. L. Peritoneal adhesions: aetiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg, 2001, 18: 260–273.
  • diZerega G. S. Peritoneum, peritoneal healing, and adhesion formation. In: diZerega G. S. (ed.). Peritoneal Surgery. New York, Springer, 2000, pp. 3–37.
  • Holmdahl L. The role of fibrinolysis in adhesion formation. Eur J Surg Suppl, 1997, 577: 24–31.
  • diZerega G. S. Biochemical events in peritoneal tissue repair. Eur J Surg Suppl, 1997, 577: 10–16.
  • Halcox J. P., Deanfield J. E. Beyond the laboratory: clinical implications for statin pleiotropy. Circulation, 2004, 109 (21 suppl 1): II42-II48.
  • Bruni F., Pasqui A. L., Pastorelli M., Bova G., Di Renzo M., Cercigani M., Leo A., Auteri A., Puccetti L. The effect of atorvas-tatin on different fibrinolysis mechanisms in hypercholesterolemic subjects. Int J Cardiol, 2004, 95: 269–274.
  • Rosenson R. S. Statins in atherosclerosis: lipid-lowering agents with anti-oxidant capabilities. Atherosclerosis, 2004, 173: 1–12.
  • Schonbeck U., Libby P. Inflammation, immunity, and HMG-CoA reductase inhibitors: statins as anti-inflammatory agents ? Circulation, 2004, 109 (suppl 1): II18-II26.
  • Haslinger B., Goedde M. F., Toet K. H., Kooistra T. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering. Kidney Int, 2002, 62: 16111619.
  • Suzumura K., Yasuhara M., Tanaka K., Odawara A., Narita H., Suzuki T. An in vitro study of the hydroxyl radical scavenging property of fluvastatin, and HMG-CoA reductase inhibitor. Chem Pharm Bul, 1999, 47: 1010–1012.
  • Beltowski J., Wójc Lcka G., Jamroz A. The differential effect of 3-hydroxy-3-methylglutarylcoenzyme A reductase inhibitors on plasma para-oxonase 1 activity in the rat. Pol J Pharmacol, 2002, 54: 661–671.
  • Fischetti F., Carretta R., Borotto G., Durigutto P., Bulla R., Meroni P. L., Tedesco F. Fluvastatin treatment inhibits leucocyte adhesion and extravasation in models of complement-mediated acute inflammation. Clin Exp Immunol, 2004, 135: 186–193.
  • Jahovic N., Gedik N., Ercan F., Sirvanci S., Yüksel M., Sener G., Alican I. The effects of statins on experimental colitis in normoc-holesterolemic rats. Scand J Gastroenterol, 2006, 41: 954–962.
  • Evans D. M., McAree K., Guyton D. P., Hawkins N., Stakleff K. Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions. Am J Surg, 1993, 165: 229–232.
  • Bergman I., Loxley R. Two improved and simplified methods for the spectrophotometric determination of hdroxyproline. Ann Chem, 1963, 35: 1961–1971.
  • Bickell N. A., Federman A. D., Aufses A. H. Jr. The influence of time on the risk of bowel resection in complete small bowel obstruction. J Am Coll Surg, 2005, 201: 847–854.
  • Wilson M. S., Ellis H., Menzies D., Moran B. J., Parker M. C., Thompson J. N. A review of the management of small bowel obstruction: members of the Surgical and Clinical Adhesions Research Study (SCAR). Ann R Coll Surg Engl, 1999, 81: 320328.
  • Becker J. M., Dayton M. T., Fazio V. W., Beck D. E., Stryker S. J., Wexner S. D., Wolff B. G., Roberts P. L., Smith L. E., Sweeney S. A., Moore M. The prevention of postoperative abdominal adhesions by a sodium hyaluronate-based bioresorbable membrane: a prospective, randomized, doubleblind multi-centre study. J Am Coll Surg, 1996, 183: 297–306.
  • Fevang B. T., Fevang J., Lie S. A., S0reide O., Svanes K., Viste A. Long-term prognosis after operation for adhesive small bowel obstruction. Ann Surg, 2004, 240: 193–201.
  • Aarons C. B., Cohen P. A., Gower A., Reed K. L., Leeman S. E., Stucchi A. F., Becker J. M. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity. Ann Surg, 2007, 245: 176–184.
  • Tiwari A., Bansal V., Chugh A. et al. Statins and myotoxicity: a therapeutic limitation. Expert Opin Drug Saf, 2006, 5: 651666.
  • Kucuk H. F., Kaptanoglu L., Kurt N., Uzun H., Eser M., Bingul S., Torlak O. A., Akyol H. The role of simvastatin on postoperative peritoneal adhesion formation in an animal model. Eur Surg Res, 2007, 39: 98–102.
  • Weber C., Erl W., Weber K. S., Weber P. C. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholes-terolaemia. J Am Coll Cardiol, 1997, 30: 1212–1217.
  • Franzoni F., Quinones-Galvan A., Regoli F., Ferrannini E., Galetta F. A comparative study of the in vitro anti-oxidant activity of statins. Int J Cardiol, 2003, 90: 317–321.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.